市场调查报告书
商品编码
1541821
分叉病变市场报告(按类型(单支架、双支架)、应用(冠状血管、週边血管)和地区)2024-2032Bifurcation Lesions Market Report by Types (One-Stent, Two-Stent), Application (Coronary Vascular, Peripheral Vascular), and Region 2024-2032 |
IMARC Group年,全球分叉病变市场规模达24亿美元。
分叉病变是指邻近重要侧支(SB)起点的冠状动脉变窄。由于血流湍流和高剪切应力,容易形成动脉粥状硬化斑块。使用分析、手术持续时间、X 光照射和长期追踪等技术进行治疗。此外,三维(3D)血管摄影和多层电脑断层扫描用于测量分叉角。随着设备、影像、辅助药物治疗和血管通路的进步,全球复杂的分叉病变病例的治疗已成为可能。
冠状动脉疾病(CAD)发生率的显着增加增加了分叉病变的风险。这是推动市场成长的关键因素之一。除此之外,创新设备的批准、保险覆盖范围的扩大和成像方式的改进也正在加强市场的成长。此外,老年人口的增加(更有可能患上医疗疾病),以及各国政府为报销而采取的支持性倡议,正在支持市场的成长。医疗旅游业的成长、微创(MI)手术需求的不断增加以及医疗基础设施的改善是促进市场成长的其他因素。除此之外,正在进行的新型治疗技术研究正在推动市场发展。例如,研究人员正在研究 Szabo 2 支架技术对具有高危害风险或 SB 闭塞致命后果的复杂分叉病变的有效性。此外,对支架和球囊的广泛临床试验,加上熟练医疗保健专业人员数量的增加,预计将降低与分叉病变治疗相关的风险,并对市场产生积极影响。
The global bifurcation lesions market size reached US$ 2.4 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 3.7 Billion by 2032, exhibiting a growth rate (CAGR) of 4.6% during 2024-2032.
A bifurcation lesion refers to the narrowing of the coronary artery adjacent to the origin of a significant side branch (SB). It is prone to develop atherosclerotic plaque due to turbulent blood flow and high shear stress. It is treated using techniques like analysis, procedure duration, X-ray exposure, and long-term follow-up. Moreover, three-dimensional (3D) angiography and multi-slice computed tomography are utilized for measuring the bifurcation angles. With the advances in devices, imaging, adjunctive pharmacotherapy, and vascular access, the management of complex cases of bifurcation lesions is becoming possible worldwide.
A significant rise in the occurrence of coronary artery disease (CAD) is increasing the risk of developing bifurcation lesions. This represents one of the key factors bolstering the market growth. Besides this, the approval of innovative devices, increasing insurance coverage, and improving imaging modalities are also strengthening the market growth. Moreover, the rising geriatric population, which is more likely to develop medical ailments, along with supportive initiatives undertaken by governments of various countries for reimbursement, is supporting the market growth. The increasing medical tourism, the escalating demand for minimally invasive (MI) procedures and the improving healthcare infrastructure are some of the other factors contributing to the growth of the market. Apart from this, the ongoing research on novel treatment techniques is driving the market. For instance, researchers are studying the effectiveness of the Szabo 2-stent technique for complex bifurcations lesions with high compromise risk or fatal consequences of SB occlusion. Furthermore, a wide range of clinical trials on stents and balloons, in confluence with the increasing number of skilled healthcare professionals, is anticipated to decrease risks associated with bifurcation lesions treatment and influence the market positively.
IMARC Group provides an analysis of the key trends in each sub-segment of the global bifurcation lesions market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on types and application.
One-Stent
Two-Stent
Coronary Vascular
Peripheral Vascular
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being Boston Scientific Corporation, Cardinal Health, Medtronic plc, Spectranetics (Koninklijke Philips N.V.) and Terumo Corporation.